The US NIH state that OAS is a likely…

In the last few days researchers from the Vaccine Research Center at the US NIH released a paper for peer review on the performance of a new mRNA vaccine targeting Omicron variant, delivered as a ‘booster’ after two doses of mRNA vaccine targeting the original Wuhan strain (ie, the current type of covid vaccine).

Read →